(Q40511008)

English

Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season

scientific article published on 16 March 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 September 2017

Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season (English)

1 reference

Europe PubMed Central

21 September 2017

multicenter clinical trial

0 references

1 reference

based on heuristic

inferred from title

Seizaburo Kashiwagi

10

object named as

Seizaburo Kashiwagi

1 reference

Europe PubMed Central

21 September 2017

author name string

Naoki Kawai

1

1 reference

Europe PubMed Central

21 September 2017

Hideyuki Ikematsu

2

1 reference

Europe PubMed Central

21 September 2017

Norio Iwaki

3

1 reference

Europe PubMed Central

21 September 2017

Ietaka Satoh

4

1 reference

Europe PubMed Central

21 September 2017

Takashi Kawashima

5

1 reference

Europe PubMed Central

21 September 2017

Tetsunari Maeda

6

1 reference

Europe PubMed Central

21 September 2017

Kiyomitsu Miyachi

7

1 reference

Europe PubMed Central

21 September 2017

Nobuo Hirotsu

8

1 reference

Europe PubMed Central

21 September 2017

Takeshi Shigematsu

9

1 reference

Europe PubMed Central

21 September 2017

language of work or name

0 references

publication date

16 March 2005

1 reference

Europe PubMed Central

21 September 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

21 September 2017

40

1 reference

Europe PubMed Central

21 September 2017

9

1 reference

Europe PubMed Central

21 September 2017

1309-1316

1 reference

Europe PubMed Central

21 September 2017

Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group

1 reference

https://api.crossref.org/works/10.1086%2F429241

21 January 2018

Influenza virus neuraminidase inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F429241

21 January 2018

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

1 reference

https://api.crossref.org/works/10.1086%2F429241

21 January 2018

Oseltamivir: a review of its use in influenza

1 reference

https://api.crossref.org/works/10.1086%2F429241

21 January 2018

Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1086%2F429241

21 January 2018

Early administration of oral oseltamivir increases the benefits of influenza treatment

1 reference

https://api.crossref.org/works/10.1086%2F429241

21 January 2018

Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment

1 reference

https://api.crossref.org/works/10.1086%2F429241

21 January 2018

Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza

1 reference

https://api.crossref.org/works/10.1086%2F429241

21 January 2018

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

1 reference

https://api.crossref.org/works/10.1086%2F429241

21 January 2018

Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F429241

21 January 2018

Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses

1 reference

https://api.crossref.org/works/10.1086%2F429241

21 January 2018

Cytokines in the pathogenesis of influenza

1 reference

https://api.crossref.org/works/10.1086%2F429241

21 January 2018

Identifiers

1 reference

Europe PubMed Central

21 September 2017

1 reference

Europe PubMed Central

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40511008&oldid=1899769911"